Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical, is headquartered in Cambridge, Massachusetts. Alongside our boundary-pushing global R&D unit, Takeda Oncology’s proven commercialization capabilities allow us to quickly respond to the diverse and ever-changing needs of patients, healthcare providers and health systems around the world. We are a force of more than 2,000 dedicated oncology professionals, driven by a patient-focused entrepreneurial spirit and commitment to agility, even as our organization grows in size and scope.
Our mission remains constant — we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. We are working every day to achieve our aspiration to cure cancer. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
Takeda Oncology Here2Assist™
Takeda Oncology Here2Assist™ is a comprehensive support program committed to helping patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their treatment.
Visit www.Here2Assist.com or call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.
For information on co-pay assistance, visit the Takeda Oncology Co-Pay Assistance Program at www.TakedaOncologyCopay.com.*
*Not all patient support services listed are available for each product.
VELCADE® is a part of the Takeda Oncology Here2Assist family, but eligible patients and providers can receive financial support through the VELCADE Reimbursement Assistance Program (VRAP). The VRAP enrollment form is available at www.VELCADE-hcp.com.